N-acetil-D-manosamina, mínimo 98 %, 250 mg, envase de vidrio

(2E)-1-(3-chlorophenyl)-3-(5-methylthiophen-2-yl)prop-2-en-1-one, 95.0%, 10g

2,3-Dimethoxybenzylamine, 95.0%, 25g

2-Octyn-1-ol, 98+%, 1g

5-(Difluoromethyl)pyridine-2-carboxylic acid, 97%, 5g

(4-Methoxytetrahydro-2H-pyran-4-yl)methanol, 98%, 100mg

2-(4-Amino-3-methyl-pyrazol-1-yl)-2-methyl-propanenitrile, 98%, 500mg

2-Butylsuccinic acid, 97%, 100mg

Methyl 2-cyclobutylideneacetate, 95+%, 1g

N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)sulfonyl]glycine, 1g

3-Amino-4-chloro-benzenesulfonamide, 95.0%, 250mg

N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine dihydrochloride, 98%, 5g

D-(+)-Ribonic-gamma-lactone, 95.0%, 5g